Digital & Innovation
AstraZeneca-UNSW partner to boost the Australian startup ecosystem
In a landmark announcement, UNSW has forged a partnership with pharmaceutical company AstraZeneca to provide unprecedented access to a network of over 250 mentors from Australia, New Zealand, and around the world in supporting local startups.
Kumaran Mani, Associate Director of Business Development, Head of A.Catalyst Network ANZ & Dina Titkova, Health 10x Program Manager, UNSW Founders, joined Health Industry Hub to unveil the details of the first-of-its-kind program and AstraZeneca-UNSW Founders’ collaboration to address unmet needs in medical innovation.
News & Trends - Biotechnology
CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
MoreNews & Trends - MedTech & Diagnostics
Australia joins Medtronic trial in fight against resistant hypertension
Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]
MoreNews & Trends - MedTech & Diagnostics
Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]
MoreNews & Trends - Pharmaceuticals
Global pledge shifts visibility and action for patients with advanced breast cancer
Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]
More